Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 6/20 | 0.44 |
| ▸ | NPY1R | P25929 | 4/20 | 0.44 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.42 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.42 |
| ▸ | SIRT5 | Q9NXA8 | 2/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.38 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.38 |
| ▸ | ALB | P02768 | 1/20 | 0.37 |
| ▸ | NPY2R | P49146 | 3/20 | 0.35 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | Q9HBH1 | 1/20 | 0.34 | |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | GNPAT | O15228 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5807981 | 1.00 | NPY4R (0.44) | NPY4RNPY1RSIRT6SIRT1SIRT5 | |
| Hydrochloric Acid SCHEMBL11506342 | 0.98 | NPY4R (0.44) | NPY4RNPY1RSIRT6SIRT1SIRT5 | |
| SCHEMBL5812127 | 0.88 | SIRT6 (0.43) | NPY4RNPY1RSIRT6SIRT1SIRT5 | |
| SCHEMBL5812133 | 0.88 | SIRT6 (0.43) | NPY4RNPY1RSIRT6SIRT1SIRT5 | |
| SCHEMBL28406173 | 0.88 | SIRT6 (0.40) | NPY4RNPY1RSIRT6SIRT1SIRT5 | |
| SCHEMBL21879809 | 0.88 | NPY4R (0.44) | NPY4RNPY1RSIRT1FOLH1ERAP1 | |
| SCHEMBL5810079 | 0.88 | SIRT1 (0.43) | NPY4RNPY1RSIRT6SIRT1SIRT5 | |
| SCHEMBL27846680 | 0.87 | NPY4R (0.42) | NPY4RNPY1RFOLH1ERAP1LNPEP | |
| SCHEMBL5814333 | 0.87 | SIRT6 (0.39) | NPY4RNPY1RSIRT6SIRT1SIRT5 | |
| SCHEMBL5814337 | 0.87 | SIRT6 (0.39) | NPY4RNPY1RSIRT6SIRT1SIRT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006119283-A2 | ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE | YU RUEY J (US) | 2006-11-09 | — | — | WO | claimed |
| US-20060251597-A1 | ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE | YU RUEY J | 2006-11-09 | — | — | US | claimed |
| WO-2024073392-A1 | USE OF NONVOLATILE ANTIMICROBIALS IN FOOD PACKAGING | CSP TECHNOLOGIES, INC. (US) | 2024-04-04 | — | — | WO | disclosed |
| CN-107628937-B | Protein chemical cross-linking agent and preparation method and application thereof | 北京大学 | 2020-11-06 | — | — | CN | disclosed |
| US-9572788-B2 | Cell permeable inhibitors of anaphase promoting complex | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2017-02-21 | — | — | US | disclosed |
| US-20170029381-A1 | TETRAHYDRO-BENZOIMIDAZOLYL MODULATORS OF TGR5 | JANSSEN PHARMACEUTICA NV (BE) | 2017-02-02 | — | — | US | disclosed |
| WO-2016081889-A1 | RECOMBINANT C1 ESTERASE INHIBITOR AND USE THEREOF | OSTHER KURT BAEKGAARD (US) | 2016-05-26 | — | — | WO | disclosed |
| US-20150328214-A1 | CELL PERMEABLE INHIBITORS OF ANAPHASE PROMOTING COMPLEX | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2015-11-19 | — | — | US | disclosed |
| WO-2015160772-A1 | TETRAHYDRO-BENZOIMIDAZOLYL MODULATORS OF TGR5 | JANSSEN PHARMACEUTICA NV (BE) | 2015-10-22 | — | — | WO | disclosed |
| EP-1848817-B1 | METHOD FOR DIFFERENTIALLY DETECTING MULTIMERIC FORM FROM MONOMERIC FORM OF MULTIMER-FORMING POLYPEPTIDES | PEOPLEBIO INC (KR) | 2013-04-24 | — | — | EP | disclosed |
| US-8026070-B2 | Differential detection of multimeric and monomeric forms of multimer-forming polypeptides | PEOPLEBIO, INC. (KR) | 2011-09-27 | — | — | US | disclosed |
| US-20050245615-A1 | Composition containing polyamine transport inhibitor and use thereof | MEDIQUEST THERAPEUTICS, INC. (US) | 2005-11-03 | — | — | US | disclosed |
| US-5532267-A | Amidinonaphthyl furancarboxylate derivatives and acid addition salts therof | TORII & CO., LTD. (JP) | 1996-07-02 | — | — | US | disclosed |
| EP-0556024-B1 | Novel amidinonaphthyl furancarboxylate derivatives and acid addition salts thereof | TORII & CO LTD (JP) | 1995-08-02 | — | — | EP | disclosed |
| EP-0506468-B1 | N-substituted 4-phenyl-piperidine opioid-antagonists | LILLY CO ELI (US) | 1995-04-26 | — | — | EP | disclosed |
| US-5270328-A | Peripherally selective piperidine opioid antagonists | ELI LILLY AND COMPANY (US) | 1993-12-14 | — | — | US | disclosed |
| EP-0556024-A1 | Novel amidinonaphthyl furancarboxylate derivatives and acid addition salts thereof | TORII & CO., LTD. (JP) | 1993-08-18 | — | — | EP | disclosed |
| US-5159081-A | INTERMEDIATES OF PERIPHERALLY SELECTIVE N-CARBONYL-3,4,4-TRISUBSTITUTED PIPERIDINE OPIOID ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1992-10-27 | — | — | US | disclosed |
| EP-0506468-A1 | N-substituted 4-phenyl-piperidine opioid-antagonists | ELI LILLY AND COMPANY (US) | 1992-09-30 | — | — | EP | disclosed |
| US-4132769-A | ANTISERA AND ANTIBODIES SPECIFIC AGAINST A HUMAN CANCER ASSOCIATED PROTEIN, IMMUNOLOGY | OSTHER KURT B | 1979-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170029381-A1 | TETRAHYDRO-BENZOIMIDAZOLYL MODULATORS OF TGR5 | GLRA1, GRM5, TRHR | NPY4R 34/4885NPY1R 21/4885SIRT6 3714/4885 |
| US-20150328214-A1 | CELL PERMEABLE INHIBITORS OF ANAPHASE PROMOTING COMPLEX | CDC20, BUB1B, BUB1 | NPY4R 4868/4885NPY1R 4837/4885SIRT6 2491/4885 |
| US-20050245615-A1 | Composition containing polyamine transport inhibitor and use thereof | SLC7A1, SRM, SLC16A1 | NPY4R 1052/4885NPY1R 339/4885SIRT6 621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.